Filament Health Corp
- Country
- Ownership
- -
- Employees
- 13
- Market Cap
- -
- Introduction
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
Phase 2
Not yet recruiting
- Conditions
- Stimulant Use Disorder
- Interventions
- Drug: PEX010-Assisted TherapyDrug: PEX010(01)
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Filament Health Corp.
- Target Recruit Count
- 86
- Registration Number
- NCT06666010
PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study
Phase 2
Not yet recruiting
- Conditions
- Opioid Use Disorder
- Interventions
- Drug: PEX010-Assisted Therapy
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Filament Health Corp.
- Target Recruit Count
- 10
- Registration Number
- NCT06608459
© Copyright 2025. All Rights Reserved by MedPath